open access

Vol 9, No 5 (2008): Practical Diabetology
Original articles (translated)
Published online: 2008-10-23
Get Citation

Diabetic Retinopathy: more patients, less laser. A longitudinal population-based study in Tayside, Scotland

James H. Vallance, Peter J. Wilson, Graham P. Leese, Ritchie McAlpine, Caroline J. MacEwen, John D. Ellis
Diabetologia Praktyczna 2008;9(5):233-240.

open access

Vol 9, No 5 (2008): Practical Diabetology
Original articles (translated)
Published online: 2008-10-23

Abstract


INTRODUCTION. We aim to correlate the incidence of diabetic retinopathy and maculopathy requiring laser treatment with the control of risk factors in the diabetic population of Tayside, Scotland, for the years 2001-2006.
MATERIALS AND METHODS. Retinal laser treatment, retinal screening, and diabetes care databases were linked for calendar years 2001-2006. Primary end points were the numbers of patients undergoing first or any laser treatment for diabetic retinopathy or maculopathy. Mean HbA1c and blood pressure and retinal screening rates were followed over the study period.
RESULTS. Over 6 years, the number of patients with diabetes in Tayside increased from 9694 to 15 207 (57% increase). The number of patients receiving laser treatment decreased from 222 to 138 and first laser treatments decreased from 100 (1.03% of diabetic population) to 56 (0.37%). The number of patients with type 2 diabetes treated for maculopathy decreased from 180 in 2001 to 103 in 2006 (43% reduction; p = 0.03). Mean HbA1c decreased for type 1 and type 2 diabetic populations (p < 0.01) and a reduction in blood pressure was observed in type 2 diabetic patients (p < 0.01). The number of patients attending annual digital photographic retinopathy screening increased from 3012 to 11 932.
CONCLUSIONS. Laser treatment for diabetic maculopathy in type 2 diabetic patients has decreased in Tayside over a six-year period, despite an increased prevalence of diabetes and increased screening effort. We propose that earlier identification of type 2 diabetes and improved risk factor control has reduced the incidence of maculopathy severe enough to require laser treatment.

Abstract


INTRODUCTION. We aim to correlate the incidence of diabetic retinopathy and maculopathy requiring laser treatment with the control of risk factors in the diabetic population of Tayside, Scotland, for the years 2001-2006.
MATERIALS AND METHODS. Retinal laser treatment, retinal screening, and diabetes care databases were linked for calendar years 2001-2006. Primary end points were the numbers of patients undergoing first or any laser treatment for diabetic retinopathy or maculopathy. Mean HbA1c and blood pressure and retinal screening rates were followed over the study period.
RESULTS. Over 6 years, the number of patients with diabetes in Tayside increased from 9694 to 15 207 (57% increase). The number of patients receiving laser treatment decreased from 222 to 138 and first laser treatments decreased from 100 (1.03% of diabetic population) to 56 (0.37%). The number of patients with type 2 diabetes treated for maculopathy decreased from 180 in 2001 to 103 in 2006 (43% reduction; p = 0.03). Mean HbA1c decreased for type 1 and type 2 diabetic populations (p < 0.01) and a reduction in blood pressure was observed in type 2 diabetic patients (p < 0.01). The number of patients attending annual digital photographic retinopathy screening increased from 3012 to 11 932.
CONCLUSIONS. Laser treatment for diabetic maculopathy in type 2 diabetic patients has decreased in Tayside over a six-year period, despite an increased prevalence of diabetes and increased screening effort. We propose that earlier identification of type 2 diabetes and improved risk factor control has reduced the incidence of maculopathy severe enough to require laser treatment.
Get Citation
About this article
Title

Diabetic Retinopathy: more patients, less laser. A longitudinal population-based study in Tayside, Scotland

Journal

Clinical Diabetology

Issue

Vol 9, No 5 (2008): Practical Diabetology

Pages

233-240

Published online

2008-10-23

Bibliographic record

Diabetologia Praktyczna 2008;9(5):233-240.

Authors

James H. Vallance
Peter J. Wilson
Graham P. Leese
Ritchie McAlpine
Caroline J. MacEwen
John D. Ellis

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl